Orchestra BioMed Holdings Income Statement (2020-2026) | OBIO

Income Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.87M0.40M1.16M1.10M1.16M0.92M0.42M0.26M0.62M0.78M0.99M0.25M0.87M0.84M0.86M30.92M0.11M
Cost of Revenue (Quarter)
0.04M0.06M0.06M0.05M0.04M0.05M0.04M0.05M0.03M0.04M0.07M0.06M0.04M0.05M0.05M0.05M0.03M
Gross Profit (Quarter)
0.82M0.34M1.11M1.05M1.12M0.86M0.38M0.21M0.59M0.73M0.92M0.20M0.82M0.79M0.81M30.87M0.08M
Operating items
Research & Development (Quarter)
3.47M5.03M5.90M7.54M8.25M8.50M8.56M8.51M9.11M11.13M11.60M10.97M13.48M13.85M14.03M16.82M15.78M
Selling, General & Administrative (Quarter)
0.07M0.06M0.06M2.48M2.95M5.28M3.33M4.41M5.32M6.34M4.18M5.90M6.47M5.67M5.90M6.26M6.26M7.10M7.29M6.37M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)
-0.60M-0.21M-0.21M0.08M0.60M0.91M1.21M-0.34M0.96M0.88M0.92M0.52M0.17M-0.04M-0.52M-0.51M1.39M
Operating Expenses (Quarter)
0.07M0.06M0.06M5.99M8.04M11.23M10.93M12.71M13.87M14.94M12.74M15.04M17.64M17.33M16.93M19.79M20.16M21.17M24.16M22.19M
Operating Income (Quarter)
-0.10M-0.09M-0.09M-5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-14.52M-12.48M-14.42M-16.86M-16.34M-16.68M-18.92M-19.33M-20.31M6.75M-22.08M
EBIT (Quarter)
-0.10M-0.09M-0.09M-5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-14.52M-12.48M-14.42M-16.86M-16.34M-16.68M-18.92M-19.33M-20.31M6.75M-22.08M
Non-operating items
Non Operating Investment Income (Quarter)
-0.22M1.73M-0.31M-1.20M-0.03M-0.06M0.02M0.05M0.00M-0.01M0.12M0.13M-0.01M-0.02M0.03M0.01M-0.10M
Other Non Operating Income (Quarter)
0.68M-0.01M-0.04M
Non Operating Income (Quarter)
0.92M1.11M1.02M0.90M0.92M0.52M0.17M-0.04M-0.52M-0.76M-0.82M
Net income details
EBT (Quarter)
-0.13M-0.12M-0.12M-5.36M-7.89M-10.45M-10.16M-11.90M-16.96M-22.02M-12.20M-15.80M-25.19M-17.62M-16.10M-19.38M-21.57M-20.54M6.39M-24.75M
Profit After Tax (Quarter)
-0.09M-0.09M-0.09M-5.73M-7.85M-10.28M-9.75M-10.94M-12.05M-13.30M-12.82M-13.46M-15.98M-15.30M-16.26M-18.75M-19.36M-20.80M6.26M-20.69M
Income from Non-Controlling Interests (Quarter)
-0.09M
Income from Continuing Operations (Quarter)
-0.13M-0.12M-0.12M-5.36M-7.89M-10.45M-10.16M-11.90M-16.96M-22.02M-12.20M-15.80M-25.19M-17.62M-16.10M-19.38M-21.57M-20.54M6.39M-24.75M
Consolidated Net Income (Quarter)
-0.13M-0.12M-0.12M-5.36M-7.89M-10.45M-10.16M-11.90M-16.96M-22.02M-12.20M-15.80M-25.19M-17.62M-16.10M-19.38M-21.57M-20.54M6.39M-24.75M
Income towards Parent Company (Quarter)
-0.13M-0.12M-0.12M-5.36M-7.89M-10.45M-10.16M-11.90M-16.96M-22.02M-12.20M-15.80M-25.19M-17.62M-16.10M-19.38M-21.57M-20.54M6.39M-24.75M
Preferred Dividend Payments (Quarter)
-0.04M
Net Income towards Common Stockholders (Quarter)
-0.13M-0.12M-0.12M-5.36M-7.89M-10.45M-10.16M-11.90M-16.96M-22.02M-12.20M-15.80M-25.19M-17.62M-16.10M-18.75M-21.57M-20.54M6.39M-20.66M
Additional items
EPS (Basic) (Quarter)
-0.01-0.01-0.01-0.26-0.39-0.76-0.62-0.43-0.49-0.62-0.37-0.44-0.70-0.47-0.44-0.49-0.56-0.390.13-0.33
EPS (Diluted) (Quarter)
-0.01-0.01-0.01-0.58-0.39-0.76-0.62-0.43-0.49-0.62-0.37-0.44-0.70-0.47-0.44-0.49-0.56-0.390.13-0.33
Shares Outstanding (Quarter)
16.00M20.45M20.45M20.45M20.45M13.72M16.43M27.64M34.61M35.24M33.23M35.78M35.80M37.62M36.82M38.24M38.39M52.19M47.75M62.72M
Shares Outstanding (Diluted) (Quarter)
20.45M20.45M20.45M9.23M20.45M13.72M16.43M27.64M34.61M35.24M33.23M35.78M35.80M37.62M36.82M38.24M38.39M52.19M47.75M62.72M
EBITDA (Quarter)
-0.10M-0.09M-0.09M-5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-14.52M-12.48M-14.42M-16.86M-16.34M-16.68M-18.92M-19.33M-20.31M6.75M-22.08M
Interest Expenses (Quarter)
0.03M0.03M0.03M0.24M0.26M0.39M0.33M0.35M4.00M7.50M-0.28M1.38M8.33M1.28M-0.58M0.46M2.24M0.23M0.36M2.68M